IBDEI087 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3538,2)
 ;;=^5133582
 ;;^UTILITY(U,$J,358.3,3539,0)
 ;;=I69.944^^18^220^29
 ;;^UTILITY(U,$J,358.3,3539,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3539,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Lt Lower Nondominant Side
 ;;^UTILITY(U,$J,358.3,3539,1,4,0)
 ;;=4^I69.944
 ;;^UTILITY(U,$J,358.3,3539,2)
 ;;=^5133585
 ;;^UTILITY(U,$J,358.3,3540,0)
 ;;=I69.932^^18^220^30
 ;;^UTILITY(U,$J,358.3,3540,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3540,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Lt Upper Dominant Side
 ;;^UTILITY(U,$J,358.3,3540,1,4,0)
 ;;=4^I69.932
 ;;^UTILITY(U,$J,358.3,3540,2)
 ;;=^5133580
 ;;^UTILITY(U,$J,358.3,3541,0)
 ;;=I69.934^^18^220^31
 ;;^UTILITY(U,$J,358.3,3541,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3541,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Lt Upper Nondominant Side
 ;;^UTILITY(U,$J,358.3,3541,1,4,0)
 ;;=4^I69.934
 ;;^UTILITY(U,$J,358.3,3541,2)
 ;;=^5133583
 ;;^UTILITY(U,$J,358.3,3542,0)
 ;;=I69.941^^18^220^32
 ;;^UTILITY(U,$J,358.3,3542,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3542,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Rt Lower Dominant Side
 ;;^UTILITY(U,$J,358.3,3542,1,4,0)
 ;;=4^I69.941
 ;;^UTILITY(U,$J,358.3,3542,2)
 ;;=^5133581
 ;;^UTILITY(U,$J,358.3,3543,0)
 ;;=I69.943^^18^220^33
 ;;^UTILITY(U,$J,358.3,3543,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3543,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Rt Nondominant Side
 ;;^UTILITY(U,$J,358.3,3543,1,4,0)
 ;;=4^I69.943
 ;;^UTILITY(U,$J,358.3,3543,2)
 ;;=^5133584
 ;;^UTILITY(U,$J,358.3,3544,0)
 ;;=I69.931^^18^220^34
 ;;^UTILITY(U,$J,358.3,3544,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3544,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Rt Upper Dominant Side
 ;;^UTILITY(U,$J,358.3,3544,1,4,0)
 ;;=4^I69.931
 ;;^UTILITY(U,$J,358.3,3544,2)
 ;;=^5007558
 ;;^UTILITY(U,$J,358.3,3545,0)
 ;;=I69.933^^18^220^35
 ;;^UTILITY(U,$J,358.3,3545,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3545,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Rt Upper Nondominant Side
 ;;^UTILITY(U,$J,358.3,3545,1,4,0)
 ;;=4^I69.933
 ;;^UTILITY(U,$J,358.3,3545,2)
 ;;=^5007559
 ;;^UTILITY(U,$J,358.3,3546,0)
 ;;=I69.998^^18^220^42
 ;;^UTILITY(U,$J,358.3,3546,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3546,1,3,0)
 ;;=3^Cerebrovascular Disease,Sequelae,Unspec
 ;;^UTILITY(U,$J,358.3,3546,1,4,0)
 ;;=4^I69.998
 ;;^UTILITY(U,$J,358.3,3546,2)
 ;;=^5007572
 ;;^UTILITY(U,$J,358.3,3547,0)
 ;;=I69.928^^18^220^43
 ;;^UTILITY(U,$J,358.3,3547,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3547,1,3,0)
 ;;=3^Cerebrovascular Disease,Speech/Language Deficits,Unspec
 ;;^UTILITY(U,$J,358.3,3547,1,4,0)
 ;;=4^I69.928
 ;;^UTILITY(U,$J,358.3,3547,2)
 ;;=^5007557
 ;;^UTILITY(U,$J,358.3,3548,0)
 ;;=I69.965^^18^220^37
 ;;^UTILITY(U,$J,358.3,3548,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3548,1,3,0)
 ;;=3^Cerebrovascular Disease,Paralytic Syndrome,Bilateral,Unspec
 ;;^UTILITY(U,$J,358.3,3548,1,4,0)
 ;;=4^I69.965
 ;;^UTILITY(U,$J,358.3,3548,2)
 ;;=^5007566
 ;;^UTILITY(U,$J,358.3,3549,0)
 ;;=I69.962^^18^220^38
 ;;^UTILITY(U,$J,358.3,3549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3549,1,3,0)
 ;;=3^Cerebrovascular Disease,Paralytic Syndrome,Lt Dominant Side
 ;;^UTILITY(U,$J,358.3,3549,1,4,0)
 ;;=4^I69.962
 ;;^UTILITY(U,$J,358.3,3549,2)
 ;;=^5133588
 ;;^UTILITY(U,$J,358.3,3550,0)
 ;;=I69.964^^18^220^39
 ;;^UTILITY(U,$J,358.3,3550,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3550,1,3,0)
 ;;=3^Cerebrovascular Disease,Paralytic Syndrome,Lt Nondominant Side
 ;;^UTILITY(U,$J,358.3,3550,1,4,0)
 ;;=4^I69.964
